Can-Fite BioPharma Statistics
Total Valuation
CANF has a market cap or net worth of $5.91 million. The enterprise value is -$808,507.
| Market Cap | 5.91M |
| Enterprise Value | -808,507 |
Important Dates
The last earnings date was Tuesday, September 8, 2026, before market open.
| Earnings Date | Sep 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CANF has 4.29 million shares outstanding. The number of shares has increased by 196.15% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.29M |
| Shares Change (YoY) | +196.15% |
| Shares Change (QoQ) | +72.20% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 2.81% |
| Float | 6.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.59 |
| Forward PS | 29.26 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.60 |
| Quick Ratio | 3.17 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -211.37% and return on invested capital (ROIC) is -132.55%.
| Return on Equity (ROE) | -211.37% |
| Return on Assets (ROA) | -77.12% |
| Return on Invested Capital (ROIC) | -132.55% |
| Return on Capital Employed (ROCE) | -166.93% |
| Weighted Average Cost of Capital (WACC) | 4.11% |
| Revenue Per Employee | $81,000 |
| Profits Per Employee | -$1.91M |
| Employee Count | 5 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.14% in the last 52 weeks. The beta is -0.02, so CANF's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -81.14% |
| 50-Day Moving Average | 2.56 |
| 200-Day Moving Average | 3.32 |
| Relative Strength Index (RSI) | 33.26 |
| Average Volume (20 Days) | 32,220 |
Short Selling Information
The latest short interest is 55,612, so 1.84% of the outstanding shares have been sold short.
| Short Interest | 55,612 |
| Short Previous Month | 61,837 |
| Short % of Shares Out | 1.84% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, CANF had revenue of $405,000 and -$9.55 million in losses. Loss per share was -$3.26.
| Revenue | 405,000 |
| Gross Profit | 405,000 |
| Operating Income | -9.73M |
| Pretax Income | -9.55M |
| Net Income | -9.55M |
| EBITDA | -9.73M |
| EBIT | -9.73M |
| Loss Per Share | -$3.26 |
Balance Sheet
The company has $7.04 million in cash and $49,000 in debt, with a net cash position of $6.99 million or $1.63 per share.
| Cash & Cash Equivalents | 7.04M |
| Total Debt | 49,000 |
| Net Cash | 6.99M |
| Net Cash Per Share | $1.63 |
| Equity (Book Value) | 4.86M |
| Book Value Per Share | 1.13 |
| Working Capital | 5.78M |
Cash Flow
In the last 12 months, operating cash flow was -$9.51 million and capital expenditures -$2,000, giving a free cash flow of -$9.51 million.
| Operating Cash Flow | -9.51M |
| Capital Expenditures | -2,000 |
| Depreciation & Amortization | 2,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -9.51M |
| FCF Per Share | -$2.22 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,402.96% |
| Pretax Margin | -2,358.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CANF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -196.15% |
| Shareholder Yield | -196.15% |
| Earnings Yield | -161.62% |
| FCF Yield | -160.94% |
Analyst Forecast
The average price target for CANF is $7.50, which is 296.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.50 |
| Price Target Difference | 296.83% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 235.26% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
CANF has an Altman Z-Score of -32.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -32.41 |
| Piotroski F-Score | 2 |